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Micronutrient and iron supplementation and effective anti-
malarial treatment synergistically improve childhood anaemia
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1 Unit of Infectious Diseases, Karolinska Institutet, Karolinska Hospital, Stockholm, Sweden
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Summary The control of childhood anaemia in malaria holoendemic areas is a major public health challenge for which
an optimal strategy remains to be determined. Malaria prevention may compromise the development of
partial immunity. Regular micronutrient supplementation has been suggested as an alternative but its effec-
tiveness remains unsettled. We therefore conducted a randomised placebo-controlled intervention trial with
207 Tanzanian children aged 5 months to 3 years on the efficacy of supervised supplementation of low-dose
micronutrients including iron (Poly Vi-Sol with iron) three times per week, with an average attendance of
$ 90%. The mean haemoglobin (Hb) level increased by 8 g/l more in children on supplement (95% CI 3–12)
during the 5-month study. All age groups benefited from the intervention including severely anaemic subjects.
The mean erythrocyte cell volume (MCV) increased but Hb in children $ 24 months improved indepen-
dently of MCV and no relation was found with hookworm infection. The data therefore suggest that
micronutrients other than iron also contributed to Hb improvement. In the supplement group of children
who had received sulfadoxine-pyrimethamine (SP) treatment, the mean Hb level increased synergistically 
by 22 g/l (95% CI 13–30) compared to 7 g/l (95% CI 3–10) in those without such treatment. Supplementation
did not affect malaria incidence. In conclusion, micronutrient supplementation improves childhood 
anaemia in malaria holoendemic areas and this effect is synergistically enhanced by temporary clearance of
parasitaemia. 
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Introduction
Childhood anaemia represents a major health problem in
sub-Saharan Africa. It may impair mental and motor
development in infants and children (Idjradinata & Pollitt
1993), and transfusion-requiring anaemia is a challenge to
health facilities in areas where both malaria and HIV infec-
tion are prevalent (Schellenberg et al. 1999). Anaemia is
multifactorial and the result of a synergism of different
causes (Fleming & Werblinska 1982; Newton et al. 1997).
Malaria and iron deficiency are known major contributors to
anaemia (Trowbridge et al. 1993; Greenwood 1997). However,
nutritional deficiencies of micronutrients other than iron may
also affect haemoglobin (Hb) status (Northrop-Clewes et al.
1996). In malaria holoendemic areas, the main aetiologies
vary according to age, e.g. malaria being most important in
small children, low dietary iron availability manifesting
during the weaning period (Tatala et al. 1998), and blood loss
due to hookworm infection occurring in older children
(Brooker et al. 1999).
Oral iron supplementation is a worldwide practice to pre-
vent anaemia in children, although the absorption of daily
iron supplements is inefficient and decreases logarithmically
over time (Viteri et al. 1995). Iron supplementation twice
weekly is as efficacious as daily supplementation in improv-
ing Hb levels in preschool children with low iron status
(Schultink et al. 1995). Spacing of iron doses leads to greater
compliance (Palupi et al. 1997), lower costs, and is associated
with a reduction of side effects (Angeles-Agdeppa et al.
1997). Nutritional deficiency of vitamin B2 (riboflavin)
imposes limitations on the absorption and use of iron and
is common in tropical areas (Powers & Bates 1987). Iron
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absorption is facilitated by vitamin C (Mao & Yao 1992);
maximum Hb levels were achieved by supplementation with a
combination of iron and vitamin A in Guatemalan children
(Mejia & Chew 1988). 
In children with malaria, however, regular iron supplemen-
tation may exert little or no effect on Hb levels (Vaughan
et al. 1977; Oppenheimer et al. 1986; Schneider et al. 1995;
van den Hombergh et al. 1996), and studies in tropical areas
have raised concerns that iron supplementation may increase
susceptibility to infections, particularly malaria and pneu-
monia (Smith et al. 1989; van den Hombergh et al. 1996;
Nwanyanwu et al. 1996; Oppenheimer 1998). Supplemen-
tation with both vitamins and iron was associated with a
trend towards higher parasitaemias in Gambian children
(Bates et al. 1987), whereas other studies could not demon-
strate a similar increased susceptibility to infection (van
Hensbroek et al. 1995; Menendez et al. 1997). Exacerbation
of malaria infection may be an early response to iron treat-
ment (Murray et al. 1978), or may be detected later when iron
stores are repleted (Oppenheimer et al. 1986). The conflicting
results on malaria-related effects by oral iron supplemen-
tation may depend on the dose and duration of iron treat-
ment (Oppenheimer 1998). Age, inherited disorders of globin
genes, diet, previous exposure to malaria, malaria trans-
mission and efficacy of antimalarials have also been impli-
cated as interacting factors (Oppenheimer 1998). 
Combined vitamin–mineral supplements are widely used
in industrialized countries and have also been recommended
to children and pregnant women in tropical areas (Alnwick
1998; Tatala et al. 1998). Children aged 6–24 months are par-
ticularly at risk of micronutrient deficiencies, being depen-
dent on complementary food containing low amounts of
bioavailable micronutrients and phytate, a micronutrient
absorption inhibitor (Gillooly et al. 1983; Thu et al. 1999).
We wanted to assess the effect of prophylactic supplemen-
tation with micronutrients and iron on Hb levels in an holo-
endemic area, and if, and how, prompt malaria treatment
promoted or interacted with such an effect. The impact of
supplementation on malaria morbidity was also assessed.
This randomised, placebo-controlled community-based study
investigated the impact of oral prophylactic supplementation
three times a week on Tanzanian children aged 5 months to
3 years.
Methods
Study population
The study was conducted in Fukayosi village, Bagamoyo dis-
trict of coastal Tanzania, from June to November 1995, dur-
ing the seasonal peak of perennial malaria transmission.
Members of the village government (the 10 cell leaders) con-
ducted a census of all children aged 5 months to 3 years. Of
220 children enumerated, the mothers of 217 children
attended a public meeting where the objectives and method-
ology of the study were described. At the time of study regis-
tration, the parents of 211 children agreed to participate and
provided oral informed consent. Formal exclusion criteria for
enrolment were migration plans, the presence of congenital
malformations and Hb concentration , 50 g/l at baseline,
requiring immediate treatment. After exclusion, a cohort of
207 children were enrolled. Each child was given an identity
number and demographic details were noted and confirmed
from the Mother and Child Health Card. The children were
randomly allocated to the supplement group (group A) or the
placebo group (group B) by a computer-generated number
table.
Study design
Children of group A received the micronutrient preparation
Poly Vi-Sol with Iron (Mead Johnson Nutritional Group, a
Bristol-Myers Squibb Company), the contents of which are
shown in Table 1. The supplement was directly imported
from the US manufacturer and did not require refrigeration.
One ml was given three times a week on alternate days under
supervision. Group B received a placebo preparation of one
ml, corresponding to one mg, promethazine hydrochloride
(Elys Ltd, Dar es Salaam, Tanzania) in an identical dosing
regimen. The supplement and placebo had different colours
to facilitate correct administration. However, neither the
research assistants involved in the project nor the mothers of
the children knew the treatment code. All children were to
receive a total of 56 doses over 5 months administered during
home visits by six research assistants who were assigned
30–35 children each. Attendance of children during home
visits was recorded and any perceived adverse effects were
noted. The two principal investigators supervised the per-
formance of the research assistants. On a few occasions
during temporary travel, the mothers gave the doses to their
children.
Two cross-sectional surveys, at study start and end, deter-
mined baseline and outcome data. All children were then
clinically examined by one of the principal investigators,
including axillary temperature, body weight and spleen size.
Capillary blood (40 ml) was collected for thick blood films
and haematological measurements. For active case detection
of clinical malaria episodes, all children were seen fortnightly
by the research team at the village dispensary for axillary
temperature measurement. Capillary blood for analyses of
Hb S and HIV-antibodies and a stool specimen were collected
at two of these regular visits. For passive malaria case detec-
tion, children with a history of fever would report to the dis-
pensary either on the mother’s initiative or by referral from a
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research assistant during home visits on alternate days. One
team medical assistant and one nurse were on duty at the vil-
lage dispensary around the clock, 7 days a week. At least one
of the principal investigators was present daily.
Clinical malaria episodes and follow-up
In all children with a measured axillary temperature
$ 37.5 8C, a standardized medical examination was per-
formed to rule out fever conditions other than malaria and to
evaluate the clinical severity of the fever episode. Capillary
blood was collected for immediate preparation and examin-
ation of a thick blood film, with an additional 40 ml pre-
diluted for haematological measurements. The prediluted
specimen was transported in an insulated container for one
hour before being analysed and the result was available at the
dispensary the following day. A Plasmodium falciparum
asexual parasite density . 4000 per ml, estimated at immedi-
ate slide examination in the field, was considered indicative of
a clinical malaria episode requiring chloroquine treatment.
Treatment with chloroquine syrup (Elyquine® by Elys Ltd,
Dar-es-Salaam, Tanzania) was given in accordance with
Ministry of Health guidelines. A team nurse supervised the
intake of 25 mg/kg over three days and the child was observed
at the dispensary for 20 min after each dose. In case of vomit-
ing, a full dose was repeated. The axillary temperature was
measured daily and, 3 days after starting treatment, capillary
blood was again collected for a thick blood film and haema-
tological parameters. Additional treatment with sulfadoxine-
pyrimethamine (SP) was given if a child showed clinical signs
of treatment failure (WHO 1996), i.e. if the condition of the
patient deteriorated while on chloroquine treatment or if
recrudescence of symptoms occurred within 14 days of start-
ing treatment. A follow-up capillary blood specimen for
haematological analysis and a bloodslide were collected after
each clinical malaria episode, at the regular fortnightly dis-
pensary visit or immediately after day 14. Clinical malaria
episodes appearing from day 14 onwards were assumed to be
due to re-infection and were treated as new episodes and
handled as described.
If a child was diagnosed with a bacterial infection, anti-
biotics were provided that would not affect parasitaemia.
Laboratory methods
Blood slides were stained with 5% Giemsa stain. The asexual
parasite densities were estimated by counting parasites
against 200 white cells, assuming a standard leukocyte count
of 8000/ml. If less than 10 parasites were recorded per 200
white cells, estimation was made against another 300 leuco-
cytes. The final examination of all slides was performed by
one of the principal investigators.
Capillary blood collection was standardized and per-
formed by only two team members. For haematological mea-
surements, an automated haematological analyser was used
(Cell-Dyn 610™, Abbott laboratories). Daily commercial
quality controls of Hb and mean erythrocyte cell volume
(MCV) were performed. The coefficient of variation for the
within-sample precision of the Hb estimate was , 1%, both
for immediately run samples and after a 6-h delay in analysis.
As an indicator of iron status, MCV was used rather than
serum ferritin and erythrocyte protoporphyrin due to the
influence of repeated malaria episodes on the latter estimates
(Stoltzfus et al. 1997). The MCV was not corrected for reticu-
Poly Vi-Sol with Recommended Daily Allowance, percent‡
Iron drops, —————————————————
per one ml dose , 1 year 1–4 years
Vitamin A, IU 1500 100 060
Vitamin D, IU 0400 100 100
Vitamin E, IU 0005 100 050
Vitamin C, mg 0035 100 085
Vitamin B1, mg 0000.5 100 070
Vitamin B2, mg 0000.6 100 075
Niacin, mg 0008 100 090
Vitamin B6, mg 0000.4 100 060
Iron, mg § 0010 067 100
*Due to instability in solution, neither folic acid nor vitamin B12 was added.
†Recommended dose is one ml daily by the manufacturer, Mead Johnson Nutritional Group, a
Bristol-Myers Squibb Company.
‡According to the manufacturer.
§Elemental iron, from 27 mg ferrous sulphate.
Table 1 Contents of micronutrient supple-
mentation to group A (Poly Vi-Sol with Iron
drops*) The dose given was 1 ml three times a
week†
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locyte count, since an Hb steady state level was assumed to
have been reached after 5 months’ supplementation. Haemo-
globin S was determined by a solubility test (Cook & Raper
1971) and a positive result was confirmed by haemoglobin
electrophoresis. HIV infection was determined by an ELISA
test for HIV antibodies (Behring) and confirmed by Western
blot when positive. Results of the HIV test were blinded and
only available after study termination. Stool examination for
geohelminths was qualitative and performed by the formalin-
aether concentration technique (Ash & Orihel 1987).
Statistical methods
Randomization and data entry were performed with Epi-
Info™ 6.2; data were analysed in JMP™ 3.1 (SAS Institute
Inc.) and STATISTICA™ 5.5. (StatSoft Inc.). We used
Pearson’s chi-square test to compare proportions, and the
paired t-test or analysis of variance to compare normally dis-
tributed continuous data. The Wilcoxon rank-sum test was
employed for sparse data. Multiple linear regression analysis
was performed on the change in Hb concentration during the
study as dependent variable with baseline Hb added as a
covariate. Data transformation was performed on correlated
independent variables. The change in MCV was analysed in a
similar way.
Children were not excluded from analyses after treatment
for a clinical malaria episode. Attention was thus given to the
frequency of antimalarial treatment, since a potential higher
treatment rate in one group could lead to subsequent parasite
suppression by residual blood concentration of antimalarials.
Severe anaemia was defined as an Hb concentration , 80 g/l,
and Hb levels . 110 g/l were considered normal (CDC 1989).
Red cell microcytosis was defined according to age, as
MCV , 70 in children , 24 months and MCV , 73 in chil-
dren $ 24 months (Oski 1993).
Ethical considerations
Ethical clearance for this study was obtained from the Ethical
Committee of Karolinska Institutet in Stockholm (#95 152)
and from the Muhimbili University College of Health
Sciences in Dar-es-Salaam. The supplement Poly Vi-Sol with
Iron was a gift from Mead Johnson Nutritional Group, but
the study had no commercial affiliations.
Results
Study population
Of 211 children registered, four were excluded due to their
initial Hb , 50 g/l. Baseline characteristics of the 207 ran-
domized children are displayed in Table 2. Twelve children
did not finish the study (six in each group) due to refusal
(five) or migration (seven). Baseline characteristics of these 12
children, including age and Hb, were similar to those com-
pleting the study. Hence analysis comprised the 195 children
who completed the study: 98 children in group A (supplement
group) and 97 children in group B (placebo group).
Children of both group A and B received a median of 55 of
the scheduled 56 doses of supplementation or placebo (inter-
quartile range (IQR) for group A: 52–56, and for group B:
53–56). Only eight children (two in group A and six in group
B) received less than 42 (75%) doses. The mean iron dose to
infants from group A was 1.4 mg per kg body weight (mean
body weight at baseline 7.2 kg). The children . 24 months
received 0.9 mg iron per kg and dose (mean body weight
11.6 kg). There were no side-effects due to the intervention in
either group. Median attendance at the fortnightly cross-
sectional visits was 100% in both groups. The overall attend-
ance during home visits three times per week was 93% in
group A and 90% in group B (P 5 0.14). During the study
period, 143/367 (39%) of fevers (from malaria and other
causes) were recorded during active case detection, and 224
(61%) were found by passive reporting. Three children were
admitted to hospital for gastro-enteritis or malaria but none
had a blood transfusion and they continued to be followed up
during and after hospital admission.
Haemoglobin AS was detected in 46 (24%) of all subjects
but no child had the HbSS genotype. Hookworm was diag-
nosed in 25 (13%) children and 19 of these were $ 18 months
old. None was HIV positive.
Supplement group A Placebo group B
(n 5 104) (n 5 103)
Mean age (months) 6SD 19 6 9 20 6 8
Mean weight (kg) 6SD 9.4 6 2.2 9.7 6 2.0
Mean Hb (g/L) 6SD 86 6 17 90 6 16
Mean MCV (fl) 6SD 69 6 8 68 6 8
Prevalence of parasitaemia 93/104 (89%) 93/103 (90%)
Median parasite density (per ml) 3600 (IQR 800–9600) 2600 (IQR 800–8300)
Table 2 Baseline characteristics of study
participants
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Effect on haematological values
Haemoglobin levels before and after the intervention are dis-
played in Table 3. At baseline, 174 (89%) children were
anaemic (Hb , 110 g/l) and 58 (30%) were severely anaemic
(Hb , 80 g/l). The mean Hb concentration increased by
10 g/l in group A but only by 2 g/l in group B (mean differ-
ence 8 g/l (95% confidence interval, CI, 3–12)). The mean Hb
level in children with severe anaemia at baseline improved
more in group A (20 g/l) than in group B (12 g/l), P 5 0.03.
No child with a normal baseline Hb became severely anaemic
after supplementation.
The baseline Hb concentration was linearly related to age
(Spearman rank correlation coefficient 0.50 (P , 0.001)), and
29 (50%) of all severe anaemia cases were recorded in chil-
dren , 12 months who constituted 23% of the study popu-
lation. Of 1254 Hb estimates, the results of three were
, 50 g/l.
Red cell microcytosis was recorded in 117 (60%) children
at baseline (Table 3). The MCV was linearly related to age
(Spearman rank correlation coefficient 0.31 (P , 0.001)).
During the study, MCV increased 3.4 fl in group A and 0.3 fl
in group B (mean difference 3.1 fl (95% CI, 1.7–4.5)). In a
multiple linear regression model, both the intervention and
low MCV at baseline were highly significant explanatory
variables for the increase in MCV during the study. The ad-
dition of age or body weight did not contribute significantly
to the fit of the regression equation.
A regression model of the increase in Hb concentration
during the study is presented in Table 4. After adjusting for
baseline Hb level, variables that were tested for significance
(P , 0.10) but not retained in the model were: number of
doses of supplement/placebo; MCV; increase in MCV; inci-
dence of clinical malaria episodes; chloroquine treatment;
weight; and age. In contrast, intervention group and anti-
malarial treatment with sulfadoxine-pyrimethamine (SP)
were highly significant dependent variables. In the final
model, the two-way interaction term between intervention
group and SP treatment was significant (Table 4). Hence,
comparisons at each level of intervention group and SP treat-
ment were made (Table 5). Within the group of SP-treated
children, group A and group B children did not differ in age
(P 5 0.28) or mean baseline Hb (P 5 0.75). SP treatment
increased Hb by 6 g/l (95% CI 2 0.3–13) in unsupplemented
children and by 15 g/l (95% CI 8–22) in supplemented
subjects (Table 5). The total increase in mean Hb in
Table 3 Haemoglobin concentration (Hb) and mean cell volume (MCV) by age, before and after five months supplementation (group A) or
placebo (group B)
Mean Hb (g/l) 6SD Mean MCV (fl) 6SD
———————————————— ——————————————————
Age (months)* Group N Start Finish Difference Start Finish Difference
5–11 A 29 73 6 14 090 6 17 217 6 18 67.9 6 7.5 71.0 6 7.3 23.1 6 5.2
5–11 B 15 78 6 17 086 6 18 208 6 16 65.3 6 8.0 65.5 6 8.5 20.2 6 2.9
12–23 A 38 88 6 16 094 6 15 206 6 16 67.1 6 7.9 73.1 6 7.5 26.0 6 7.0
12–23 B 49 88 6 14 091 6 13 203 6 14 67.5 6 7.4 68.2 6 7.1 20.7 6 3.2
24–36 A 31 95 6 13 102 6 15 207 6 12 73.5 6 7.1 74.0 6 6.0 20.5 6 4.6
24–36 B 33 98 6 15 097 6 12 021 6 12 70.3 6 7.1 70.1 6 6.9 20.2 6 3.9
All A 98 86 6 16 095 6 16 210 6 16 69.4 6 8.0 72.8 6 7.0 23.4 6 6.2
All B 97 90 6 16 092 6 14 202 6 14 68.1 6 7.5 68.4 6 7.3 20.3 6 3.4
*Age at study start
Table 4 Multiple linear regression model on change in haemoglobin
concentration between study start and end. Whole model test,
R2 5 0.40, P , 0.001. Baseline Hb was added as a covariate
Regression coefficient Significance 
Explanatory variable (95% CI) level, p
Group A/Group B 23.3 (–0.6–7.2) , 0.10
SP-treatment 22.7 (–3.4–8.8) , 0.38
Interaction term
SP-treatment * Group A/B 29.9 (1.5–18.3) , 0.02
Baseline Hb 20.5 (–0.4 to –0.6) , 0.001
Intercept 044.2 (34.1–54.3) , 0.001
Table 5 Increase in haemoglobin concentration (g/l) 6SD, i.e. differ-
ence in mean Hb between study start and end, in children with or
without second-line sulfadoxine-pyrimethamine (SP) treatment and
supplementation (group A) or placebo (group B) N 5 number of
subjects
Group A Group B
SP treatment 22 6 19 (n 5 21) 7 6 20 (n 5 20)
No SP treatment 071 6 3 (n 5 77) 1 6 12 (n 5 77)
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supplemented children who had received SP treatment was
22 g/l (95% CI 13–30) (Table 5). The subgroups were not
randomised, however, and the children who received SP treat-
ment were on average 6 months (95% CI 3–9) younger and
their mean baseline Hb was 7 g/l (95% CI 1–12) lower than in
those without such treatment. The synergistic effect of
micronutrient supplementation and SP treatment was, how-
ever, confirmed after adjusting for age and baseline Hb in a
regression model.
SP was administered in 49 clinical malaria episodes with
chloroquine treatment failure to 21 children of group A and
20 children of group B (Table 5). In group A children, one
course of SP improved Hb by 15 g/l (95% CI 4–26) if it was
administered during the last three study months, and by 5 g/l
(95% CI 25–15) if it was given during the first two months.
The increase in Hb by the supplement was statistically not
related to haemoglobin genotype (not shown). The haemo-
globin level was unrelated to hookworm infection.
Effects on malaria
We recorded 271 clinical malaria episodes, 149 in group A
and 122 in group B. The mean clinical malaria incidence rate
in group A was 0.28 episodes/person-month vs. 0.24 in group
B (P 5 0.25). Similarly, there was no difference between group
A and B in the incidence of fever episodes not due to malaria,
P 5 0.95 (n 5 96). Neither the geometric mean parasite den-
sity at the time of malaria diagnosis, nor the geometric mean
asymptomatic parasitaemia during follow-up of clinical
malaria episodes were statistically different between the two
groups (P 5 0.75 and P 5 0.35, respectively). There was no
difference between the two groups in parasitaemia at the
study end, including the prevalence of parasitaemia and the
proportion parasitaemias . 4000/ml and . 10000/ml (data
not shown). Adjusting for the sickle cell trait did not affect
the lack of difference in clinical malaria incidence rate
between the two groups.
Discussion
Public health interventions to prevent childhood anaemia in
malaria holoendemic areas need to combine effectiveness
with feasibility and sustainability. This study was undertaken
to investigate whether spacing the administration of low-dose
micronutrients and iron to young children with anaemia
retained its efficacy on long-term Hb concentrations, despite
the presence of malaria parasitaemia, and to evaluate the
interactive influence of malaria case management regimen on
Hb levels (Tanzania 1997). The supplementation and the
malaria case management procedures were both considered
feasible and potentially sustainable measures for the preven-
tion of childhood anaemia, addressing the nutritional
deficiency state as well as the malaria infection.
Haemoglobin levels were improved by the supplementation
and no adverse effects were recorded. All age groups, i.e. up
to three years of age, benefited from the intervention, includ-
ing severely anaemic subjects (Table 3). In severely anaemic
children, even a modest increase in Hb may make a difference
between a potentially lethal and non-lethal malaria episode.
However, the relatively small study group and close follow-up
did not allow investigation of the possible prevention of
transfusion-requiring anaemia. The extensive rise in mean Hb
in supplemented infants and a recorded Hb improvement in
infants of the placebo group suggested that, in addition to
the intervention effect on Hb, a statistical ‘regression to the
mean’ of Hb levels occurred with age (Table 3) (Nwanyanwu
et al. 1996).
Improved iron status, as measured by the increase in MCV,
was observed in supplemented subjects , 24 months
(Table 3). Increase in MCV was related to a low baseline
MCV, predominantly occurring in the youngest children and
indicating past iron deficit and therefore an increased absorp-
tion of iron during the study period (Hulten et al. 1995).
Infants were given a higher iron dose per kg body weight than
toddlers because iron requirements are considerably higher
during infancy than in older children (Table 1) (Dallman
1986; National Research Council 1989). However, body
weight did not contribute significantly to the regression
model on the increase in MCV, suggesting that the iron dose
received per kg body weight may not have been crucial for
MCV improvement.
The absorption of iron is a function of the quantity and
predominant form (haem or non-haem) of iron in the food,
the interaction between iron and other dietary components,
and the regulation of iron absorption. A cereal diet low in
vitamin C, which enhances the absorption of low bio-
availability iron, is a major cause of anaemia in Tanzania
(Hallberg et al. 1986; Tatala et al. 1998). As body stores
diminish, there is a compensatory increase in the absorption
of iron, where high bio-availability iron may double its
uptake whilst the absorption of non-haem iron increases only
slightly (Dallman et al. 1993). However, when iron in a well-
absorbed form such as ferrous sulphate is added to foods, the
amount absorbed is inversely proportional to its concen-
tration (Saarinen & Siimes 1977). Moreover, iron intake has
an immediately blocking effect on further absorption, so that
intermittent supplementation timed to gastrointestinal cell
renewal may be more efficient than a daily supplement sched-
ule (Fairweather-Tait et al. 1985). Therefore, the intermittent
administration of iron in a low dose together with vitamin C
most likely promoted absorption.
Our results are in contrast to those by Bates et al. (1987),
who failed to detect an improvement in haematological
indices in Gambian children by high doses of iron and
© 2000 Blackwell Science Ltd 701
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vitamin B and C. In The Gambia, the Hb drop associated
with heavy seasonal malaria transmission may be difficult to
reverse without the aid of antimalarial chemoprophylaxis
(McGregor et al. 1966). A further point may be that the sup-
plement used did not contain vitamin A which improves Hb
concentration (Suharno et al. 1993). The authors suggested
that more frequent dosing of micronutrients may have im-
proved the outcome, but the implementation of large-scale
daily supplementation programmes seems unrealistic (Palupi
et al. 1997).
The mean Hb level of group A children $ 24 months im-
proved independently of MCV (Table 3). This suggests that
the Hb improvement in older children may have been due to
effects of micronutrients other than iron. The anaemia of
vitamin A deficiency is similar to iron deficiency with low
MCV and low serum iron levels (Mohanram et al. 1977).
Simultaneous administration of vitamin A and iron to chil-
dren with deficiencies of both nutrients produces a better
response with respect to serum iron, transferrin saturation
and Hb than administration of vitamin A or iron supplemen-
tation alone (Mejia & Chew 1988; Suharno et al. 1993;
Kolsteren et al. 1999). A diet deficient in vitamin B2 leads to
red cell aplasia (Lane & Alfrey 1963), and hypochromic
anaemia responding to vitamin B6 has been described in mal-
nourished patients (Foy & Kondi 1958). It is still unclear
whether vitamin C also has a direct role in haematopoiesis, or
if the anaemia in subjects with scurvy is a result of the inter-
actions of ascorbic acid with iron and folic acid metabolism.
Dietary iron deficiency in children often coexists with dietary
ascorbic acid deficiency, and children with scurvy frequently
require both iron and vitamin C to correct a microcytic
anaemia (Cohen et al. 1981). Scurvy itself may cause iron
deficiency as a consequence of external bleeding but poor
iron absorption is more important (Mao & Yao 1992;
Sharma & Mathur 1995). Finally, vitamin D deficiency rickets
has been associated with myelofibrosis and anaemia (Yetgin
et al. 1989). Hence, several micronutrients may have improved
Hb in children $ 24 months, but it could not be determined
which of these may have been most important.
Despite iron supplementation, microcytosis was still preva-
lent in most children at the end of the study (Table 3), poss-
ibly indicating the presence of undiagnosed thalassaemia
which is common in sub-Saharan Africa (Hill 1992;
Mockenhaupt et al. 1999).
The clinical malaria incidence rate and malaria para-
sitaemia were not affected by the supplement. However, un-
diagnosed thalassaemia may have protected against an
increase in malaria infection caused by the supplement
(Oppenheimer et al. 1987). The supplement also contained
vitamin A which is known to enhance immune functions,
even in individuals with adequate vitamin A levels (Ross
1992; Ribaya-Mercado 1997). Folate was not included in the
supplement as it is unstable in solution, and hence did not
reduce the antimalarial effects of SP (van Hensbroek et al.
1995). Since the frequency of antimalarial treatment was
similar in both groups, there was no differential parasite
suppression due to residual blood concentrations of anti-
malarials.
Second-line antimalarial treatment with SP to unsup-
plemented children moderately increased long-term Hb levels
although the improvement did not reach statistical signifi-
cance. Previously, short-term Hb levels have been shown to
recover on first-line SP treatment (van Hensbroek et al. 1995;
van den Hombergh et al. 1996; Verhoeff et al. 1997), as well
as on second-line SP treatment (Ekvall et al. 1998). However,
to maintain Hb levels over time, repeated antimalarial doses
may be needed. In pregnant women, presumptive SP treat-
ment prevented the development of severe anaemia (Shulman
et al. 1999), but monthly SP administration gave no haemato-
logical relief to Kenyan children exposed to intense malaria
transmission (P. Bloland, unpublished data). Weekly malaria
chemoprophylaxis with dapsone-pyrimethamine to
Tanzanian infants was more protective against severe
anaemia than daily iron supplementation (Menendez et al.
1997). Hence, for long-term effect on Hb, regular anti-
malarial intake appears to be required. However, this may
impair the development of semi-immunity, with rebounds of
both clinical malaria and severe anaemia occurring after stop-
ping chemoprophylaxis (Greenwood et al. 1995; Menendez
et al. 1997). It has been suggested that spaced doses of anti-
malarials, i.e. incomplete chemoprophylactic parasite sup-
pression, may improve Hb levels and at the same time still be
able to stimulate an immune response to malaria (Greenwood
et al. 1988). Incomplete chemoprophylactic suppression of
parasitaemia has produced a 5% increase in haematocrit in
children from holoendemic areas (Björkman et al. 1986;
Menon et al. 1990), whereas complete parasite suppression
was associated with a 10% haematocrit improvement
(McGregor et al. 1956; Bradley-Moore et al. 1985).
In the present study, second-line antimalarial treatment
with SP to supplemented children synergistically improved
the long-term Hb response (Table 5). Supplementation with
iron after antimalarial treatment is controversial, and not all
studies have shown a beneficial effect on Hb (Nwanyanwu
et al. 1996; van den Hombergh et al. 1996). Although iron
improved short-term haematological recovery after anti-
malarial therapy in Gambian children, there was no synergy
between the two treatments (van Hensbroek et al. 1995).
Menendez et al. (1997) did not detect any synergetic effect on
severe anaemia between weekly antimalarial chemoprophy-
laxis and 4 months of iron supplementation. The synergy we
observed may have been related to the effects of micro-
nutrients other than iron. After the temporary clearance of
parasitaemia and thus removal of the haematopoietic sup-
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pression (Kurtzhals et al. 1997), pre-existing nutritional de-
ficiencies may limit the Hb restitution, making vitamin sup-
plements essential for a complete bone marrow response.
Synergy was only obtained with SP treatment, i.e. when
malaria treatment was effective and parasitaemia eliminated
or substantially reduced. The synergistic effect on Hb was not
found after treatment with chloroquine, a much less effective
antimalarial in this setting (Ekvall et al. 1998). Furthermore,
the long half-life of SP may have promoted the Hb recovery
by an extended period of aparasitaemia. Subsequent analysis
of the data suggested that the synergistic effect faded when
parasitaemia recurred, although the statistical interpretation
was limited due to the small number of patients. In our study,
the mean Hb concentration improved by 26% over five
months in children receiving both supplement and SP treat-
ment. These data suggest that a spaced supplement regimen
containing micronutrients and iron together with SP treat-
ment for malaria may improve childhood anaemia in holo-
endemic areas. The synergy between the two treatments leads
to a rapid Hb improvement, and the further use of sup-
plement secures a continuous rise in Hb in-between SP treat-
ments, during intervals when the antiparasitic effect may be
fading and the Hb curve flattening out. The duration and
treatment intervals under such a regimen remain to be deter-
mined, but should for practical reasons be linked to the Inte-
grated Management of Childhood Illnesses, or the Mother
and Child Health Programme and Expanded Programme on
Immunization (EPI 1) (Alonso González et al. 2000; Nicoll
2000).
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